Page:United States Statutes at Large Volume 105 Part 2.djvu/376

From Wikisource
Jump to navigation Jump to search
This page needs to be proofread.

105 STAT. 1328 PUBLIC LAW 102-190—DEC. 5, 1991 PART E—OTHER MATTERS SEC. 251. MEDICAL COUNTERMEASURES AGAINST BIOWARFARE THREATS. (a) FUNDING.—Of the amounts appropriated pursuant to section 201 for fiscal year 1992, not more than $53,800,000 shall be available for the medical component of the Biological Defense Research Program (BDRP) of the Department of Defense. Ob) LIMITATIONS.— (1) No funds appropriated or otherwise made available for the Department of Defense for fiscal year 1992 may be obligated or expended for product development, or for research, development, testing, or evaluation, of medical countermeasures against a biowarfare threat except for medical countermeasures against a validated biowarfare threat agent or a potential (far-term) biowarfare threat agent. (2) Of the funds made available pursuant to subsection (a), not more than $10,000,000 may be obligated or expended for research, development, testing, and evaluation of medical countermeeisures against potential (far-term) biowarfare threats. (c) DEFINITIONS. —In this section: (1) The term "biowarfare threat agent" means a biological agent that— (A) is named in the biological warfare threat list published jointly by the Defense Intelligence Agency (DIA) and the Armed Forces Medical Intelligence Center (AFMIC); or (B) is identified as a biowarfare agent by the Deputy Chief of Staff of the Army for Intelligence in accordance with Army regulations applicable to intelligence support for the medical component of the Biological Defense Research Program. (2) The term "validated biowarfare threat agent" means a biowarfare threat agent that is being or has been developed or produced for weaponization within 10 years, as assessed and determined jointly by the Defense Intelligence Agency and the Armed Forces Medical Intelligence Center. (3) The term "potential (far-term) biowarfare threat agent" means a biowarfare threat agent that is an emerging or future biowarfare threat, is the object of research by a foreign threat country, and will be ready for weaponization in more than 10 years and less than 20 years, as assessed and determined jointly by the Defense Intelligence Agency and the Armed Forces Medical Intelligence Center. (4) The term "weaponization" means incorporation into usable ordnance or other militarily useful means of delivery. SEC. 252. UNIVERSITY RESEARCH INITIATIVE. Of the amounts authorized to be appropriated for fiscal year 1992 pursuant to section 201, $182,373,000 shall be available for research and development under the University Research Initiative program of the Department of Defense, of which $30,000,000 shall be available only for research in advanced manufacturing technologies and industrial processes. SEC. 253. GRANT FOR THE INSTITUTE FOR ADVANCED SCIENCE AND TECHNOLOGY. (a) AUTHORITY TO MAKE GRANT.— Of the amount authorized to be appropriated pursuant to section 201 for the Defense Agencies, and